Education
About Us
Working with TipRanks
Follow Us
Takeda Pharmaceutical Company (TAK)
:TAK
Earnings Data
Report Date
Jan 29, 2026Before Open (Confirmed)
Period Ending
2025 (Q3)Consensus EPS Forecast
0.15Last Year’s EPS
0.05Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook with strong pipeline advancements and strategic partnerships, but was overshadowed by significant losses from VYVANSE's generic impact and currency headwinds affecting profitability.Company Guidance
Growth in Launch Products
Launch products grew 5.3% at constant exchange rate (CER), with expectations for higher growth in the second half of the fiscal year.
Pipeline Advancements
Positive Phase III studies for rusfertide and oveporexton, and expected Phase III data for zasocitinib in psoriasis by the end of the calendar year.
Innovent Biologics Partnership
Strategic partnership with Innovent Biologics to expand oncology pipeline with differentiated assets like IBI363 and IBI343.
Oveporexton's Potential
Oveporexton demonstrates significant improvement in narcolepsy type 1 symptoms and is on track for U.S. filing later in the year.
Strong Cash Flow
Adjusted free cash flow of JPY 525.4 billion, including improvements in working capital.
TAK Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
TAK Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Oct 30, 2025 | $13.77 | $13.23 | -3.92% |
Jul 29, 2025 | $14.31 | $14.32 | +0.07% |
May 08, 2025 | $15.06 | $14.27 | -5.25% |
Jan 30, 2025 | $13.03 | $13.41 | +2.92% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Takeda Pharmaceutical Company (TAK) report earnings?
Takeda Pharmaceutical Company (TAK) is schdueled to report earning on Jan 29, 2026, Before Open (Confirmed).
What is Takeda Pharmaceutical Company (TAK) earnings time?
Takeda Pharmaceutical Company (TAK) earnings time is at Jan 29, 2026, Before Open (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is TAK EPS forecast?
TAK EPS forecast for the fiscal quarter 2025 (Q3) is 0.15.